Table 1 Participants’ baseline characteristics
From: Predictors of delayed culture conversion among Ugandan patients
Characteristic | Number | |
|---|---|---|
Mean age in years (SD) | 100 | 36.2 (11.6) |
Age categories, n (%) | ||
18–24 | 20 (20.0) | |
25–49 | 64 (64.0) | |
> =50 | 16 (16.0) | |
Gender, male, n (%) | 100 | 80 (80.0) |
Marital status, n (%) | 92 | |
Married | 54 (58.7) | |
Separated/Divorced | 8 (8.7) | |
Single/widowed | 30 (32.6) | |
Occupationa, n (%) | 92 | |
Peasant | 16 (17.4) | |
Professional | 9 (9.8) | |
Service | 18 (19.6) | |
Unskilled manual | 37 (40.2) | |
Student | 6 (6.5) | |
Business | 6 (6.5) | |
Transport mode to clinic, n (%) | 91 | |
Motorbike | 34 (37.4) | |
Car | 16 (17.6) | |
Taxi | 41 (45.1) | |
District of residence, n (%) | 100 | |
Bushenyi | 9 (9.0) | |
Isingiro | 21 (21.0) | |
Mbarara | 70 (70.0) | |
Relationship with Domiciliary treatment monitor, n (%) | 97 | |
Parental family | 42 (43.3) | |
Own family | 22 (22.7) | |
Friends/in-laws | 33 (34.0) | |
Current smoker, n (%) | 89 | 35 (39.3) |
TB treatment regimen, n (%) | 100 | |
Standard regimen (R10mg/kg) | 33 (33.0) | |
Regimen 1 (R15mg/kg) | 33 (33.0) | |
Regimen 2 (R20mg/kg) | 34 (34.0) | |
Clinical Parameters | ||
Mean body weight in kg (SD) | 100 | 51.2 (7.8) |
Mean BMI in Kg/m2 (SD) | 99 | 19.0 (2.4) |
BMI <18.5, n (%) | 44 (44.4) | |
Biochemical parameters | ||
Mean hemoglobin in g/dl (SD) | 100 | 11.7 (1.8) |
Hemoglobin gradeb | ||
Mild anemia, n (%) | 13 (13.0) | |
Moderate anemia, n (%) | 11 (11.0) | |
Severe anemia, n (%) | 6 (6.0) | |
Biological Parameters | ||
Baseline smear positivity, n (%) | 100 | 100 (100.0) |
Scanty | 4 (4.0) | |
1+ | 9 (9.0) | |
2+ | 25 (25.0) | |
3+ | 62 (62.0) | |
Baseline LJ positivity, n (%) | 100 | 98 (98.0) |
Colony density, n (%) | ||
Negative | 2 (2.0) | |
1+ | 4 (4.0) | |
2+ | 14 (14.0) | |
3+ | 56 (56.0) | |
4+ | 24 (24.0) | |
Baseline MGIT positivity, n (%) | 100 | 95 (95.0) |
Baseline combined LJ/MGIT positivity, n (%) | 100 | 100 (100.0) |
Mean Time-to-detection (TDD) of MTB on MGIT in days (±SD) | 95 | 13.4 ± 10.6 |
TDD of MTB on MGIT in days, <14 days, n (%) | 95 | 65 (68.4) |
Primary Isoniazid resistance, n (%) | 100 | 3 (3.0) |